Search Videos and More
Miami Cancer Institute to Present Latest Cancer Research at 2023 ASCO Annual MeetingMiami Cancer Institute, part of Baptist Health South Florida, today announced its oral and poster presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, at McCormick Place in Chicago, Illinois.
Cracking Glioblastoma’s Deadly Code: Research Focused on Improving Diagnosis and Genomics to Revolutionize CareEven with growing awareness of the devastating effects of glioblastoma, the most common and aggressive form of brain cancer, treatment options remain limited and patients typically survive just 15-18 months beyond diagnosis. Researchers at the Miami Cancer Institute and Miami Neuroscience Institute, part of Baptist Health South Florida, are focusing their efforts to advance understanding of the disease and improve diagnostic, prognostic, and therapeutic outcomes.
Lutetium-177 (177Lu) - PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Updated National Society GuidelinesThe most recent American Society of Clinical Oncology (ASCO) guidelines for the management of metastatic castration-resistant prostate cancer (mCRPC) was published in 2014.
AI: A Game-Changer in Screening MammographyDiagnostic radiologists can scroll through upwards of 25,000 mammography images per day in search of the smallest suspicious lesion. The task is extremely taxing and image interpretation is variable.
Milestone 1000th Patient Treated Using Gamma Knife at Miami Cancer InstituteLeading the fight against brain metastases, Baptist Health Miami Cancer Institute hit a new milestone recently. The center treated its 1000th patient using Gamma Knife radiosurgery, an incisionless radiation therapy that precisely targets a tumor, importantly minimizing damage to otherwise healthy brain tissue.
New Class of Drugs Show Promise in Treating Recurrent Cervical CancerWith a poor prognosis for many patients with relapsing gynecological cancers ? particularly for those who received conventional treatment only ? gynecological oncologists are on the search for novel therapies.
With a Focus on Advancing Cancer Treatments, Researchers With Baptist Health Cancer Care Focus on Trials Benefiting PatientsFrom a deep dive into genetic mutations to studies using novel therapies, physician-investigators at Miami Cancer Institute and Lynn Cancer Institute, part of Baptist Health Cancer Care, are conducting important leading edge research to advance cancer care.
Preventing Fractures in the Bone Mets PopulationPreventing fractures in patients with bone metastasis improves mobility and quality of life ? and for some, it means prolonged survival as well, according to recent studies. While not all cancer patients have access to an orthopedic oncologic specialist, it’s important that medical and radiation oncologists prioritize the referral of those with bone mets for a skeletal evaluation early in their diagnosis, says Juan Pretell, M.D., chief of musculoskeletal oncology surgery at Baptist Health Miami Cancer Institute.
Investigating Dramatic Radiation Dose Reduction For HPV-Related Head and Neck CancersIn continuing efforts to develop effective treatments with less impact on quality of life, Miami Cancer Institute is participating in a clinical trial to reduce by more than half the radiation dosage for head and neck cancers related to the human papillomavirus (HPV).
New Trojan Horse in Oncology: Antibody Drug Conjugate Offers Promise in Treatment of HER2-Low Breast CancerIn a presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, Reshma Mahtani, DO, chief of breast oncology at Miami Cancer Institute, part of Baptist Health South Florida, described ADCs as the "new Trojan horses in oncology."
Combining expertise with innovation - Multimodality skin cancer treatment at Lynn Cancer InstituteThe World Health Organization reports that nonmelanoma and melanoma skin cancers have been increasing over the last decade, highlighting the importance of early detection and treatment.
Innovations Using Hyperthermic lntraperitoneal Chemotherapy for Ovarian Cancer CareThe Miami Cancer Institute has one of the largest minimally invasive gynecologic surgical programs in the region.